Mediwin Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 38 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with UZPHARM (UZ), NAFDAC (NG) and ZAMRA (ZM). Its GMP standing is certified by CDSCO (India) and NAFDAC (NG). Customs aggregates show $2.1M of exports covering 185 molecules to 11 destinations in 2025.
| Site | FDA FEI |
|---|---|
| ahmedabad 382 330ahmedabad, India | Not on file |
| Ahmedabad, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| UZPHARM (UZ) | 23 | None |
| NAFDAC (NG) | 13 | 1 |
| ZAMRA (ZM) | 2 | None |
| CDSCO (India) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $385K | 8 |
| 2025 | Not reported | $2.1M | 11 |
| 2024 | Not reported | $2.6M | 11 |
| 2023 | Not reported | $2.3M | 12 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Mediwin Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free